Urologic radiology

, Volume 6, Issue 1, pp 74–79 | Cite as

Nephrolithiasis: Current concepts in medical management

  • John J. Pahira


Advances in renal lithiasis research have contributed to a better understanding of the many varied factors that contribute to renal calculus formation. Utilizing the newer techniques of ambulatory metabolic evaluation, we can establish a specific diagnosis in 95% of recurrent stone-formers. Since a significant percentage of initial stone for mers will never have a second episode, it is essential to establish the natural history of the patient’s stone disease prior to initiating potentially life-long medical therapy. The majority of initial stone-formers can be managed with education concerning modest dietary restrictions and increased fluid intake. For the recurrent stone-former with metabolically active stone disease, it is probably best to design medical therapy to treat the specific urinary chemical abnormality or disease process.

Key words

Renal calculi Nephrolithiasis, medical treatment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smith LH: Medical treatment of idiopathic calcium urolithiasis.Kidney 16:9–15, 1983Google Scholar
  2. 2.
    Hiatt RA, Friedman GD: The frequency of kidney and urinary tract diseases in a defined population.Kidney Int 22:63–68, 1982PubMedCrossRefGoogle Scholar
  3. 3.
    Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT: Renal stone epidemiology: a 25-year study in Rochester, Minnesota.Kidney Int 16:624–631, 1979PubMedCrossRefGoogle Scholar
  4. 4.
    Pak CYC: Medical management of nephrolithiasis.J Urol 128:1157–1164, 1982PubMedGoogle Scholar
  5. 5.
    Pak CYC, Peters P, Hurt G, Kadesky M, Fine M, Reisman D, Splann F, Caramela C, Freeman A, Britton F, Sakhaee K, Breslau NA: Is selective therapy of recurrent nephrolithiasis possible?Am J Med 71:615–622, 1981PubMedCrossRefGoogle Scholar
  6. 6.
    Ettinger B: Recurrence of nephrolithiasis: a six year prospective study.Am J Med 67:245–248, 1979PubMedCrossRefGoogle Scholar
  7. 7.
    Yendt E: Medical management of calcium stones. In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis, Baltimore: Williams and Wilkins, 1983, pp 187–209Google Scholar
  8. 8.
    Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD: Primary hyperparathyroidism: a prospective clinical study.Am J Med 50:670–678, 1971PubMedCrossRefGoogle Scholar
  9. 9.
    Robertson WG: Risk factors in calcium stone disease. In Brochis G, Finlayson B (eds),International Urinary Stone Conference, Littleton, Massachusetts: PSG Publishing Co., 1979, p 12Google Scholar
  10. 10.
    Smith LH, VanDenberg CJ, Wilson DM: Current concepts in nutrition: nutrition and urolithiasis.N Engl J Med 298:2:87–89, 1978PubMedGoogle Scholar
  11. 11.
    Pak CYC, Sakhaee K, Crowther C, Brinkley L: Evidence justifying a high fluid intake in treatment of nephrolithiasis.Ann Intern Med 93:36–39, 1980PubMedGoogle Scholar
  12. 12.
    Coe FL, Parks JH: Hyperuricosuria and calcium nephrolithiasis. Symposium on Advances of Renal Lithiasis.Urol Clin North Am 8:2:227–244, 1981PubMedGoogle Scholar
  13. 13.
    Pak CYC, Ohata M, Lawrence EC, Snyder W: The hypercalciurias: causes, parathyroid functions, and diagnostic criteria.J Clin Invest 54:387–400, 1974PubMedCrossRefGoogle Scholar
  14. 14.
    Thomas WC Jr: Medical aspects of renal calculus disease. Treatment and prophylaxis.Urol Clin North Am 1:2:261–277, 1974PubMedGoogle Scholar
  15. 15.
    Rubenstein MA, Bucy JG: Acetazolamide-induced renal calculi.J Urol 114:610–612, 1975PubMedGoogle Scholar
  16. 16.
    Gordon EE, Sheps SG: Effect of acetazolamide on citrate excretion and formation of renal calculi.N Engl J Med 256:1215–1219, 1957PubMedGoogle Scholar
  17. 17.
    Gregory JG: Hyperoxaluria and stone disease in the gastrointestinal bypass patient.Urol Clin North Am 8:2:331–351, 1981PubMedGoogle Scholar
  18. 18.
    Lafferty FW: Primary hyperparathyroidism changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests.Arch Intern Med 141:1761–1766, 1981PubMedCrossRefGoogle Scholar
  19. 19.
    Breslau NA, Pak CYC: Metabolic evaluation. In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis, Baltimore: Williams and Wilkins, 1983, pp 168–179Google Scholar
  20. 20.
    Drach G: Urinary lithiasis: In Harrison JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC (eds):Campbell’s Urology Philadelphia: W.B. Saunders 1978, pp 818–819Google Scholar
  21. 21.
    Finlayson B: Renal lithiasis in review.Urol Clin North Am 1:181–212, 1974PubMedGoogle Scholar
  22. 22.
    Rose GA: The causes and medical treatment of renal calculi.Practitioner 218:74–80, 1977PubMedGoogle Scholar
  23. 23.
    Smith L: Stone activity: In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis. Baltimore: Williams and Wilkins, 1983, pp 183–186Google Scholar
  24. 24.
    Finlayson B: Calcium stones: some physical and clinical aspects: In David DS (ed):Calcium Metabolism in Renal Failure and Nephrolithiasis. New York: John Wiley and Sons, 1977, p 371Google Scholar
  25. 25.
    Menon M: Calcium oxalate stones—management. InUrolithiasis Update 1983. Buffalo, New York: AUA Post-Graduate Course, 1983, p 6Google Scholar
  26. 26.
    Smith LH: Calcium-containing renal stones.Kidney Int 13:383–389, 1978PubMedCrossRefGoogle Scholar
  27. 27.
    Pak CYC, Fetner C, Townsend J, Brinkley L, Northcutt C, Barilla D, Kadesky M, Peters P: Evaluation of calcium urolithiasis in ambulatory patients: comparisons of results with those of inpatient evaluations.Am J Med 64:979–987, 1978PubMedCrossRefGoogle Scholar
  28. 28.
    Drach GW, Perin R, Jacobs S: Outpatient evaluation of patients with calcium urolithiasis.J Urol 121:564–567, 1979PubMedGoogle Scholar
  29. 29.
    Boyce W, Resnick M: Biochemical profiles of stone-forming patients: a guide to treatment.J Urol 121:706–710, 1979PubMedGoogle Scholar
  30. 30.
    Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslow NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman D, Peters P: Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria.Am J Med 69:19–30, 1980PubMedCrossRefGoogle Scholar
  31. 31.
    Coe FL: Nephrolithiasis: causes, classification, and management.Hosp Pract 16:33–45, 1981Google Scholar
  32. 32.
    Pak CYC: Kidney stones: various forms and treatment.Nephron 23:142–146, 1979PubMedCrossRefGoogle Scholar
  33. 33.
    Pak CYC: Physiological basis for absorptive and renal hypercalciurias.Am J Physiol 237:F414–423, 1979Google Scholar
  34. 34.
    Pak CYC: A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.Invest Urol 19:187–190, 1981PubMedGoogle Scholar
  35. 35.
    Nicar MJ, Skurla C, Sakhaee K, Pak CYC: Low urinary citrate excretion in nephrolithiasis.Urology 21:8–14, 1983PubMedCrossRefGoogle Scholar
  36. 36.
    Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC: The role of 1,25-dihydroxycholecalciferol in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.J Clin Invest 59:756–760, 1977PubMedCrossRefGoogle Scholar
  37. 37.
    Coe FL: Hyperuricosuric calcium oxalate nephrolithiasis.Kidney Int 13:418–426, 1978PubMedCrossRefGoogle Scholar
  38. 38.
    Coe FL, Raisen L: Allopurinol treatment of uric acid disorders in calcium stone formers.Lancet 1:129–131, 1973PubMedCrossRefGoogle Scholar
  39. 39.
    Meyer JL: Nucleation kinetics in the calcium oxalate sodium urate monohydrate system.Invest Urol 19:197–201, 1981PubMedGoogle Scholar
  40. 40.
    Pak CYC, Holt K, Zerwekh JE: Attentuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation.Invest Urol 17:138–140, 1979PubMedGoogle Scholar
  41. 41.
    Gregory JG, Park KY, Schoenberg HW: Oxalate stone disease after intestinal resection.J Urol 117:631–634, 1977PubMedGoogle Scholar
  42. 42.
    Pak CYC, Holt K: Nucleation and growth of brushite and calcium oxalate in urine of stone formers.Metabolism 25:665–673, 1976PubMedCrossRefGoogle Scholar
  43. 43.
    Johansson G, Backman U, Danielson BG: Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.J Urol 124:770–774, 1980PubMedGoogle Scholar
  44. 44.
    Sakhaee K, Micar M, Jacobson H, Pak CYC: Potassium alkali therapy of uric acid lithiasis may prevent complication of calcium stones (abstract).Clin Res 30:403A, 1982Google Scholar
  45. 45.
    Bell NH: Hypercalcemic and hypocalcemic disorders: diagnosis and treatment.Nephron 23:147–151, 1979PubMedCrossRefGoogle Scholar
  46. 46.
    Brenner RJ, Spring DB, Sebastian A, McSherry EM, Genant HK, Palubinskas AJ, Morris RC: Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis.N Engl J Med 307:217–221, 1982PubMedCrossRefGoogle Scholar
  47. 47.
    Yendt ER, Cohanim M: Prevention of calcium stones with thiazides.Kidney Int 13:397–409, 1978PubMedCrossRefGoogle Scholar
  48. 48.
    Broadus AE, Thier SO: Metabolic basis of renal-stone disease.N Eng J Med 300:839–845, 1979Google Scholar
  49. 49.
    Bogash M, Dowben RM: Low protein diet in the management of recurrent uric acid stones.J Urol 72:1057–1060, 1954PubMedGoogle Scholar
  50. 50.
    deVries A, Frank M: Prophylaxis of idiopathic and gouty uric acid lithiasis by allopurinol.Urol Int 22:506, 1967CrossRefGoogle Scholar
  51. 51.
    Thier SO, Segal S: Cystinuria. In Stanbury JB, Wyngarden JB, Fredrickson DS (eds):The Metabolic Basis of Inherited Disease, 4th ed. New York: McGraw-Hill, 1978, pp 1578–1592Google Scholar
  52. 52.
    Freed SZ: The alternating use of an alkalizing salt and acetazolamide in the management of cystine and uric acid stones.J Urol 113:96–99, 1975PubMedGoogle Scholar
  53. 53.
    Dahlberg PJ, Van Denberg CJ, Kurtz SB, Wilson DM, Smith LH: Clinical features and management of cystinuria.Mayo Clin Proc 52:533–542, 1977PubMedGoogle Scholar
  54. 54.
    Griffith DP: Struvite stones.Kidney Int 13:372–382, 1978PubMedCrossRefGoogle Scholar
  55. 55.
    Thompson RB, Stamey TA: Bacteriology of infected stones.Urology 2:627–633, 1973PubMedCrossRefGoogle Scholar
  56. 56.
    Griffith DP, Moskowitz PA, Carlton CE: Adjunctive chemotherapy of infection-induced staghorn calculi.J Urol 121:711–715, 1979PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Berlin Heidelberg Tokyo 1984

Authors and Affiliations

  • John J. Pahira
    • 1
  1. 1.Division of UrologyGeorgetown University School of MedicineWashington, D.C.USA

Personalised recommendations